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A Retrospective Review of Surgical Site Infection Following Caesarean Section at Mowbray 
Maternity Hospital. 
 
Sonntag K, Horak TA, Fawcus S 
Department of Obstetrics and Gynaecology, University of Cape Town, South Africa. 
 
Introduction: Pregnancy related sepsis is a major cause of maternal mortality and morbidity 
in South Africa. Caesarean section (CS) is the most important risk factor in the development 
of puerperal infection, and surgical site infection (SSI) after CS increases maternal morbidity 
as well as medical costs. Mowbray Maternity Hospital (MMH), is a secondary level, public 
maternity hospital. The caesarean section rate at MMH has increased considerably over the 
last fifteen years, and the perception has been that there have been increasing numbers of 
patients developing SSI post-CS. This study was designed to look more closely at the 
incidence of SSI and to describe the patients identified with SSI. 
Methods: This was a retrospective observational study. Cases of severe SSI, as defined by 
the Centres for Disease Control and Prevention (CDC), following CS at MMH from 
December 2011 to December 2014 were identified. Following ethical approval, patient 
records were sourced, data collected and analysed using Stata and Statistica. 
 
Results: In the 3-year study period, 14982 CS were performed with 98 patients identified 
with severe SSI. Folders were retrieved for 96 patients, with 2 patients’ folders missing and 
29 patients with a missing maternity case record (MCR). The overall incidence of severe SSI 
was 0.65%, with an incidence of 0.88% in Year 1, 0.90 in Year 2 and 0.70 in Year 3. Of the 
cases, 79 (80.6%) had been in labour, 16 (16.3%) patients had had prolonged rupture of 
membranes (PROM) and 32 (32.7%) had prolonged labour, with a median of 5 vaginal 
examinations. An emergency CS was performed in 90 (91.8%) patients, 7 (7.2%) had an 
elective CS and 1 (1.0%) patient had this data missing. Deep incisional SSI was diagnosed in 
74 (75.5%) patients and 24 (24.5%) patients were identified with organ/space SSI. 
Intravenous (IV) antibiotics was the main treatment in all 96 cases, with 23 (23.5%) patients 
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requiring a wound debridement, 17 (17.2%) a laparotomy, which proceeded to a 
hysterectomy in 12 (12.3%) patients. In the majority of cases, no organism was cultured,  
Whereas multiple organisms were cultured in 16 cases, of which 12 were identified as 
MRSA, and 18 as Klebsiella pneumoniae. There were no maternal deaths or Intensive Care 
Unit (ICU) admissions. 
 
Discussion and Conclusion: The incidence of severe SSI is in keeping with other 
institutions, with the lowest incidence being found in Year 3, which may be explained by the 
change in referral population and/ or the full implementation of the Best Care Always (BCA) 
bundles of care. Of the 98 patients with severe SSI, 80.6% had been in labour, 32.7% had 
prolonged labour and 91.8% had an emergency CS performed. These are all factors which are 
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Pregnancy related sepsis is the 5th leading cause of maternal death in South Africa.1 The 
United Nations have formed 17 Sustainable Development Goals (SDG), which build on the 
success of the Millennium Development Goals. Goal number 3 deals with health; 
specifically, child health, maternal health, Human Immunodeficiency Virus (HIV), malaria 
and other diseases. The target is to decrease global maternal mortality ratio to less than 70 per 
100 000 live births by 2030.2  
Caesarean section (CS) is the most important risk factor for puerperal infection.3,4 Puerperal 
infection is up to 20 times more common following CS than following a vaginal birth.5 
Surgical site infection (SSI) after a CS increases maternal morbidity as well as medical 
costs.6  
Mowbray Maternity Hospital (MMH) is an Obstetric and Neonatal Hospital situated in Cape 
Town, South Africa. MMH has a 130 obstetric bed capacity and has 900 to 1000 deliveries 
each month. Patients with diagnosed severe surgical site infection (SSI) post caesarean 
section are referred to the Gynaecology Department at Groote Schuur Hospital (GSH), where 
they receive appropriate treatment. In 2011/ 2012, there was a perceived increase in cases 
from MMH requiring admission to GSH for intravenous (IV) antibiotics, wound 
debridement, uterine evacuation or hysterectomy. Cases transferred to GSH were recorded 
and the numbers each month were monitored. In 2012, MMH devised a protocol aimed at 
reducing the incidence and severity of SSIs. This protocol was modelled on the Best Care 
Always (BCA) initiative, which addresses certain bundles of care that are aimed at reducing 
the rate of surgical site sepsis.7 
Puerperal sepsis following caesarean section is a key indicator of quality of care, and SSIs are 
associated with substantial morbidity, longer hospital stay and hospital readmissions.8,9 In 
addition to this, treating patients with SSI can be associated with significant financial costs.10 
Identifying possible risk factors for SSIs is essential in developing a targeted intervention to 
reduce its occurrence.11 The aim of this study was to review SSI following CS at MMH, with 
the specific objectives being  to measure the type and incidence of SSI following CS, and to 
identify any obstetric, medical or surgical factors associated with SSI in our population.  
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2. Literature Review 
 
2.1 Introduction 
Surgery dates back as early as the Neolithic period, 10200 BC-2000 BC, with one type of 
surgery being trephining, which involved making a small hole in the head, thought to cure 
migraines.12 Even in these early times, sepsis was found to be a problem and different 
methods were used as an attempt at treatment. The Sumerians used antiseptics in the form of 
beer, turpentine and vinegar, and in the Middle Ages, cauterisation was used. 
In 130-200 AD, Claudius Galen, a surgeon to the Gladiators, proposed that pus was 
mandatory for wound healing. This view was challenged one thousand years later by 
Theodoric of Borgognoni of Cervia. He claimed that wound healing required four things: 
removal of necrotic tissue, control of bleeding, as little dead space as possible, and the correct 
and careful placement of dressings.13 These opinions contested those of Galen, and he ended 
up being criticised by the Church and had his theory rejected by his peers.12 
Surgeons continued to operate in unsterile environments, often not washing their hands or 
instruments.14 Patients did not often survive surgery as a result of the anaesthetic, or due to 
overwhelming sepsis.15 Postoperative infections were described as “irritative fever”, with pus 
draining from incision sites.16  
Ignaz Philipp Semmelweiss was described as the “saviour of mothers” for his advancement in 
recognising that the incidence of puerperal fever could be reduced by introducing hand 
disinfection. In the early 19th century, thousands of women were dying of “childbed fever”, 
also described as puerperal fever. The fever occurred postpartum and was crippling. The only 
treatment available was bloodletting, which was often futile. King Henry VIII’s wife, Jane 
Seymour, is thought to have died of a puerperal fever, only two weeks after giving birth to 
Edward VI of England. Semmelweiss worked at Vienna General Hospital where he 
discovered that the two obstetric clinics had varying maternal mortality rates, of 10 and 3%. 
The one clinic trained medical students and the other, midwives. The medical students were 
involved in performing autopsies and then also seeing women in the clinic and performing 
deliveries. Semmelweiss postulated that the medical students were carrying “cadaverous” 
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particles, and after instituting handwashing with a chloride lime solution, the mortality rates 
of the clinics became comparable.17  
In 1867, Joseph Lister described a way to control infection by spraying wounds with carbolic 
acid and applying carbolic bandages. This was the first theory of antisepsis and was 
published as a ground breaking paper. In it he stated that “all the local inflammatory mischief 
and general febrile disturbance which follow severe injuries are due to the irritating and 
poisoning influence of decomposing blood or sloughs."15 
In 1891, Ernst von Bergmann initiated sterilisation of surgical instruments with heat. William 
Stewart Halsted appointed Goodyear in 1890 to create rubber gloves to use during surgery.18 
In the 1940s, Alexander Fleming discovered penicillin, which revolutionised surgery by 
making it substantially safer.19 
For many centuries, infection and sepsis has hindered surgical progress, and as William 
Williams Keen so aptly stated, “Antisepsis relieved patients from the terrors of death and 
gave to the surgeon restful nights and joyous days." 20 
 
2.2 Defining Surgical Site Infection    
The Centres for Disease Control and Prevention (CDC) developed definitions for 3 different 
types of SSIs.21 SSIs are either classified into incisional or organ/space infections, with 
incisional being further subdivided into superficial and deep. This is described in       
Appendix A. The CDC’s National Nosocomial Infections Surveillance (NNIS) developed 
uniform criteria for defining SSI, which are consistently used by surveillance and surgical 
personnel and are currently the accepted international standard.16 The literature reviewed 
showed a consistency in using the definition of SSIs as laid out by the CDC. This definition 
can be modified to SSI post-CS. A deep incisional SSI equates to a severe, deep wound 
infection with an associated pyrexia > 38⁰C, which may require IV antibiotics, surgical 
intervention in the form of wound debridement and drainage of any underlying collection. An 
organ/space SSI post-CS referred specifically to either endometritis or uterine sepsis. On 
examination, the uterus would be subinvoluted and tender. In addition, localised or 
generalised peritonitis may be elicited. Cases that did not respond to intravenous antibiotics 
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required surgical intervention in the form of uterine evacuation, explorative laparotomy with 
possible drainage of a collection, or hysterectomy. 
 
2.3 Incidence of SSI 
The incidence of SSI following CS differs between various countries, as well as between 
different centres. Patient population, varying obstetric protocols and individual patient risk 
factors are all possible explanations. One study identified cases of wound infection post-CS 
in two centres in Israel. Between 1988-2002, 19416 caesarean sections were performed, and 
of those, 726 (3.7%) cases developed wound infection, which was defined as maternal 
pyrexia with wound dehiscence, purulent discharge or local swelling, which required the 
wound to be opened.6 In China, eight centres participated in a study that surveyed SSIs from 
2005-2009. Of the 13798 CS performed, 96 patients (0.7%) met the criteria for SSI as defined 
by the CDC. Infection was diagnosed by: (i) purulent drainage from the wound; (ii) cultured 
organisms from fluid or tissue from the incision site; (iii) any further procedures: opening or 
debridement of the wound; (iv) signs of infection of the incision site: redness, warmth, 
tenderness or swelling;  (v) an abscess; or (vi) the opinion of the attending doctor.11 In a 
Norwegian publication, 29 out of 326 women (8.9%) developed a superficial SSI following 
CS over a 12 month period in 2003, using the CDC definition.22 
The incidence of puerperal sepsis related to CS has not been widely documented in South 
Africa.23 In Johannesburg at the Chris Hani Baragwanath Hospital, of the 272 women who 
had a CS over a 6-week time period in 2010, 34 (12,5%) developed an SSI. These were 
further subdivided into 30 (11.0%) being diagnosed with a mild wound infection and 4 
(1.5%) with puerperal sepsis. The patients were identified by a telephonic follow up after 14 
days of delivery or if they were readmitted for sepsis.23  
 
2.4 Puerperal Sepsis 
Puerperal sepsis is defined by the World health Organisation (WHO) as an infection of the 
genital tract that occurs at any time frame between the rupture of membranes or labour, up to 
the 42nd day postpartum, in which 2 or more of the following are present: 
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- pelvic pain 
- fever (temperature ≥ 38.5˚C) 
- abnormal vaginal discharge 
- abnormal odour of vaginal discharge 
- delay in the rate of involution of the uterus24 
Pregnancy related sepsis is caused by infections of the genital tract associated with a viable 
pregnancy.1 The first manifestation of puerperal sepsis is usually a pyrexia, which may be 
accompanied by headache, rigors, anorexia or malaise.25  
 
2.5 Microbiology 
The patient’s own skin flora is often the source of infection in SSI cases.26 Mangram et al 
(1999) identified the most common pathogens associated with various surgical disciplines. 
Obstetric and gynaecological surgeries were more predisposed to gram-negative bacilli, 
enterococci, group B streptococci and anaerobes.16 Staphylococcus, a common contaminant 
found in the skin flora, can come into contact with the underlying tissue at skin incision. 
Whilst methicillin-resistant Staphylococcus aureus (MRSA), is a pathogen that has now 
increasingly been associated with SSI.26 Wloch et al (2012) identified a causative organism in 
39.8% of SSIs, which were polymicrobial in 24%. Staphylococcus aureus was the most 
common organism (40%), with 17% being MRSA. Other organisms included anaerobic cocci 
(23%), Enterobacteriaceae (13%) and streptococci (7%).27  
 
2.6 Cost and Burden of SSIs 
SSIs are linked to an increase in patient morbidity, hospital readmissions, as well as longer 
hospital stays.8,9 In 2006, Herwaldt et al, examined the outcomes of over 3000 patients with 
post-operative nosocomial infections in a tertiary setting. Diagnosed nosocomial infections 
were associated with increased costs, longer post-operative stay, increased readmission rates, 
and increased use of antibiotics (P-value of <0.001 for all variables). Nosocomial infection 
was also significantly associated with an increase in total hospital cost (P-value < 0.001).8 
This study focused on patients that underwent general, cardiothoracic and neurosurgical 
surgeries, so it may be difficult to apply this directly to patients undergoing caesarean section. 
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A study done at the Basel University Hospital in Switzerland evaluated the economic burden 
of SSIs. This was a case control study consisting of 6283 patients. The cases of SSI were 
matched to controls in age, procedure, and a National Nosocomial Surveillance scoring 
system. The total inpatient cost was more than doubled in the cases of SSI, with an additional 
length of hospital stay of 16.8 days and an additional in-hospital antibiotic duration of 7.4 
days, compared to the controls. Most of these differences were due to organ/space SSIs.9   
Many studies have looked at the financial cost of treating SSIs following a vast array of 
different surgeries.28 SSIs resulting from surgeries which involved major organ spaces, such 
as cardiothoracics, are often associated with higher financial costs than SSIs due to smaller, 
less extensive surgeries.29 The cost of SSIs also varies according to depth of infection. SSIs 
are reported to be higher with organ/space infection, than with superficial or deep incisional 
infection.9  
 
2.7 Patient Risk Factors 
Several patient risk factors have been shown to have an association with an increased risk of 
SSI. These include, but are not limited to, obesity, cigarette smoking, hyperglycaemia, 
anaemia, and immunocompromised states, such as Human Immunodeficiency Virus 
(HIV).6,11,30,31,32 These factors can all cause delayed wound healing and a dysfunctional 
immune response in the face of bacterial colonisation. In the 2011-2013 Saving Mother’s 
Report there were 226 maternal deaths due to pregnancy related sepsis. In 206 of these deaths 
the HIV status was known, of which 137 (67%) were positive.1  
 
In obesity, there is poor perfusion of adipose tissue, which impairs wound healing and 
decreases the local immune response. Antibiotic penetration may be substandard in obese 
women, due to a standard dosage of antibiotics being given, which is not calculated according 
to weight. The incision may need to be larger, and therefore increases the amount of tissue 
that is exposed to contamination. Suturing closed the dead space in the subcutaneous tissue is 
advised as it decreases the probability of developing wound infection and dehiscence.27 
Ghuman et al (2011) found that an increased Body Mass Index (BMI) was associated with a 
higher risk of infection. In that study, the mean BMI in the case group was 34.7kg/m2  
compared to a mean of 28kg/m2 in the control group (p-value = 0.0002).33 In addition, the 
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location of the wound in the lower abdominal folds, also makes the wound difficult to keep 
clean.6,33 Schneid-Kofman et al (2005) identified that obesity was a risk factor for early 
wound infection with an odds ratio (OR) of 2.2 (95% confidence interval {CI} 1.4-2.1) and 
that obesity and diabetes increased the risk of wound infection by 9.3 times ( 95% CI 4.5-
19,2; P-value <0.001).6  
 
In a study examining the incidence of complications in women who underwent 
urogynaecological surgery, 235 obese women were matched with 194 normal weight 
controls. There was no statistical difference in the subjects who had one or more 
perioperative complication (20% obese vs 15% non-obese), but the obese participants were 
more likely to develop wound infection (adjusted OR 5.5, 95% CI 1.7-24.7; P-value <0.01).30 
In 2012, Wloch et al assessed the frequency and risk factors for surgical site infection. 
Obesity was found to be strongly associated with the development of SSIs, with the risk 
increasing with each increasing category of BMI. Overweight women had an estimated risk 
of infection of 1.6 times greater than normal weight category, and obese women 2.4 times 
greater.27   
 
Adequate oxygen levels are required for wound healing and in the case of anaemia, there are 
low levels of tissue oxygen, which promotes the risk of SSIs. Cigarette smoking interferes 
with wound healing as it can cause blood vessel constriction with secondary tissue hypoxia.31  
Gong et al (2012) identified the incidence and risk factors for SSI post-CS. The significant 
risk factors found for infection were obesity (OR 4.46 CI 1.54-12.88), normal preoperative 
haemoglobin (Hb)(OR 0.94 CI 0.91-0.98), prolonged surgery (OR 1.06 CI 1.02-1.11) and 
prophylactic antibiotics (OR 0.13 CI 0.04-0.42), all with a P-value of <0.001.11 Ghuman et al 
(2011) did not find any statistical significance between smokers and non-smokers (P-
value=0.4635).33  Diabetes mellitus was found to be a risk factor for wound sepsis by 
Schneid-Kofman et al (2005) (OR 1.4, 95% CI 1.1-1.7).6 Wloch et al (2012), found 5.6% of 
their study population to have either gestational diabetes (4.1%), type I diabetes (1.0%) or 
type II diabetes (0.4%). The risk of SSI in the diabetic patients was found to be 15.6% (95% 
CI 11.0-21.1), compared with 9.6% (95% CI 8.7-10.6) in non-diabetic patients (P-value 
<0.01).27 
Moodliar et al (2007) investigated CS complications in a high HIV prevalence setting. This 
study was conducted at King Edward Hospital in Kwa-Zulu Natal and over a 3-month period, 
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737 CSs were performed. Of the 737 cases, 23.7% were HIV negative, 25.2% HIV positive 
and 51% had an unknown status. This study was conducted in 2003-2004, where antenatal 
HIV testing was not as emphasised as it is in our setting today, where it now comprises an 
intergral part of antenatal care. In this study, wound sepsis was not shown to be higher in 
HIV positive women, with 5.4% of cases occurring in HIV positive women compared to 
8.0% in HIV negative women, and 4% of cases having an unknown HIV status. Endometritis 
however, was statistically more significant in HIV positive patients (P-value=0.004).32 
Johnson et al (2012) did not find any statistical significance with regards to HIV infection 
and puerperal infection. In that study, 34 patients were diagnosed with puerperal sepsis and 
238 did not have any evidence of puerperal sepsis. Of the patients with puerperal sepsis, 12 
were HIV positive (35%), whereas of the patients without puerperal infection, 67 (28%) were 
found to be HIV positive, with a P-value of 0.42.23  
 
2.8 Obstetric Risk Factors 
 
Obstetric risk factors that increase the incidence of post CS SSI are generally intrapartum risk 
factors, which makes SSI post CS unique when compared to elective surgery. It is often 
impossible to differentiate between infection that was introduced during labour or at the time 
of surgery. Specific obstetric factors that may have an impact on the risk of developing a SSI 
include prolonged rupture of membranes (PROM), increased number of vaginal examinations 
(VE) during labour, use of assisted delivery instruments, and disimpaction of the fetal head 
prior to CS.11,34,35 These factors increase the risk of chorioamnionitis, and the subsequent 
development of endometritis or uterine sepsis. Schneid-Kofman et al (2005) reviewed 19416 
caesarean deliveries over 14 years. Patients with PROM were more likely to have wound 
infection than those without PROM (adjusted OR 1.5, 95% CI 1.2-1.9; P-value <0.001).6 
Gong et al (2012) found that premature rupture of membranes was strongly associated with 
wound and uterine SSI following caesarean section (OR 3.73, 95% CI 1.05-13.21; P-value 
<0.003).11 Ghuman et al (2011) discovered that in their case group (25) the mean duration of 
labour was 16.5 hours and only 9.5 in the control group (50), which was  found to be 
statistically significant (P-value=0.0019).33 
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In Nigeria, Melah et al (2003) looked at 618 cases of obstructed labour and discovered that 
puerperal sepsis was the most frequent morbidity encountered post-surgical delivery. There 
was morbidity in 457 (73.9%) patients and the commonest cause of morbidity was puerperal 
sepsis 113 (24.7%).34 Piper et al (1998) concluded that meconium stained liquor (MSL) is 
associated with increased peripartum infection for all modes of delivery, when compared to 
clear amniotic fluid (44% versus 13%, relative risk {RR} 5.18, 95% CI 2.9-9.3). Meconium 
stained amniotic fluid occurs when fetal colonic contents are released in-utero. The incidence 
of maternal complications such as endometritis and chorioamnionitis has been shown to be 
increased with the presence of MSL vs clear amniotic fluid.36 
 
2.9 Patient Preparation 
The source of many pathogens involved in SSIs originate from the patient’s endogenous 
flora. When a skin incision is made, tissues are at risk of contamination with endogenous 
flora and preoperative antiseptic showering is considered to lower the skin’s microbial colony 
count. A Cochrane Review in 2007 showed that there was no clear benefit of using 
chlorhexidine compared to placebo or bar soap in preoperative showering or bathing, RR of 
SSI was 0.95 (95% CI 0.82-0.10).37 
A Cochrane Review has been published on preoperative hair removal to determine any 
relationship that different methods may have on the development of wound site sepsis. When 
comparing shaving to clipping, it was found that shaving is associated with a statistically 
significant increase in SSIs (RR 2.02, 95% CI 1.21-3.36).38 When shaving is used as a 
method of perioperative hair removal, it may result in microscopic cuts and abrasions on the 
patient’s skin, thereby compromising the protective skin barrier, which does not occur with 
clipping.26 The CDC has advised perioperative hair removal to only occur if the hair will 
interfere with the operation, and then for it to be done immediately before the surgery and 
with electric clippers.16   
Preoperative skin antisepsis is performed in theatre to remove debris and transient 
organisms.26 The skin preparation used should be hypoallergenic, safe, eradicate skin 
organisms and have long-lasting effect.39 Iodine based solutions were found to be more 
effective than chlorhexidine containing solutions across all surgical disciplines, with 
effectiveness varying depending on concentration, time left on the skin, temperature, and type 
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of skin organisms. Systemic absorption of iodine can occur after its use as a cleaning solution 
at CS, resulting in transient neonatal thyroid dysfunction and in rarer cases has led to iodine 
toxicosis. 26,40 The BCA Initiative has however recommended chlorhexidine as a pre-
operative cleaning solution due to a lower incidence of SSI when compared to povoiodine.7 
 
2.10 Operative Characteristics 
Operating theatres can themselves be a source of infection, as they may contain skin cells, 
respiratory droplets and even dust particles containing organisms. According to the CDC’s 
Guideline to Preventing Surgical Site Infection, theatres should always be kept at a positive 
pressure, and ventilation systems should always have 2 filter beds (Category 1B evidence).16 
Operative risk factors also play a vital role in an individual patient developing an SSI, and 
will further compound their risk. These include previous surgeries, the experience of the 
surgeon, operating time, and blood loss.11,23 Surgical techniques that limit blood loss, prevent 
hypothermia, and ensure careful handling of tissues, will reduce the risk of SSIs.16 
 
In Norway, Opǿien et al (2007) studied the incidence of post-caesarean SSI. Over a period of 
a year, the total rate of SSI was 8.9% of patients undergoing a CS, with no significant 
difference between elective or emergency CS. The two risk factors that were significant, were 
an operating time of more than 38 minutes (P-value=0.026, OR 2.5) and a BMI of greater 
than 30 (P-value=0.007, OR 2.8).22 A similar study was done in New Zealand by Ghuman et 
al (2011), resulting in 5% of their patients having a SSI post-caesarean section. The 
significant risk factors determined by them, consisted of an elevated BMI (P-value=0.0002), 
prolonged labour (P-value=0.0019), and an emergency procedure (P-value=0.0243).33 
Schneid-Kofman et al (2005) found that there was no increase in the incidence of SSIs in 
patients with previous CS (OR 0.98, 95% CI 0.8-1.1; P-value=0.80), and postulated that this 
was due to the patient being more experienced in the postpartum period and possibly 
mobilising sooner than the patient who had had their first CS.6 
There is scanty literature evaluating the impact that the level of experience of the surgeon, or 
the amount of blood loss has on post CS SSI. Moodliar et al (2007) found that there was no 
difference in the incidence of wound sepsis between surgeons of different grades or the time 
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of day that the surgery was performed.32 In a UK study, CS performed by a junior surgeon 




A Cochrane Review published in 2014, compared antibiotic prophylaxis vs placebo or no 
prophylaxis in women undergoing caesarean section. The result was that antibiotic 
prophylaxis reduced the risk of wound infection (RR 0.40, 95% CI 0.35-0.46, 82 studies, 
14,407 women), endometritis (RR 0.38, 95% CI 0.34-0.42, 83 studies, 13,548 women) and 
other infectious complications (RR 0.31, 95% CI 0.20-0.49, 32 studies, 6159 women) by 60 
to 70%.5 In 2014, another Cochrane review assessed the timing of antibiotic prophylaxis. It 
was found that preoperative administration of prophylactic antibiotics before the skin incision 
significantly decreased the incidence of wound infections, when compared to after cord 
clamping (wound infection {RR 0.59, 95% CI 0.44-0.81}, high quality evidence).41 The study 
set in China by Gong et al (2012), found that the lack of prophylactic antibiotics was a 
significant risk factor for SSI (P-value <0.001).11 For surgical disciplines, the treatment 
guidelines provided by The Medical Letter advise that prophylactic antibiotics are not 
continued for longer than 24 hours after surgery is completed, and 48 hours in the case of 
cardiothoracic surgery.42 
There is little evidence to support the use of an extended course of prophylactic antibiotics in 
the post-surgery period. Lyimo et al (2013) included 500 patients in their study from October 
2011 – May 2012. Patients were randomly assigned to either single dose gentamycin and 
metronidazole pre-operatively or the same antibiotics continued for 24 hours. They concluded 
that there was no significant difference between single pre-operative antibiotic prophylaxis, 
where 4.8% developed SSI, vs multiple dose antibiotic prophylaxis for 24 hours, with 6.4% 
diagnosed with SSI, in the reduction of SSI post emergency CS.43  Ijarotimi et al (2013) 
discovered that following elective CS there was no statistical significance (P-value=0.056) in 
the incidence of wound sepsis with 24 hour prophylaxis (4% incidence) when compared to 7 
day course of the same antibiotics (3% incidence), following elective CS.44  Shakya et al 
(2010) included 100 patients into their study and they were randomised to either receive 
single dose of prophylactic antibiotics or multiple doses, according to hospital policies. There 
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was no statistical difference between the 2 groups in infectious morbidity post elective CS, 
with 4 and 6% respectively diagnosed with febrile morbidity.45  
A 2014 Cochrane review recommended that additional prophylactic antibiotics be given post-
operatively to high risk patients for 24 hours and up to 5 days. These risk groups included; 
HIV positive women, patients with chorioamnionitis, patients who had more than 5 VE in 
labour and when the fetal head was pushed up vaginally.5  
 
2.12 Surgical Management of Surgical Site Infection 
Once an SSI has been diagnosed and is not responding to IV antibiotics, the next step would 
be surgical management. It is proposed that the wound be manually opened to allow free 
drainage, followed by negative pressure wound therapy and then secondary closure at a later 
stage. These methods will accelerate the healing of the wound.46 
Seffan et al (2005) reviewed relaparotomy post caesarean section, and found that the 
incidence of repeat surgery occurred in 44 out of 6120 CS (0.7%). The indications included 
uterine sepsis, haemorrhage and wound dehiscence. Surgeries performed included 
hysterectomy, artery ligation, debridement and resuturing of the initial incision.47  
 
2.13 Intervention Strategies 
Approaches aimed at preventing infection are either supported by randomised control trials 
with strong evidence that supports their use, or based on common sense and poor data.24 
Obesity, diabetes, cigarette smoking, and anaemia are all contributing risk factors that should 
be controlled, avoided, or prevented before surgery to further reduce the risk of the likelihood 
of developing a SSI.6,7,11,24,27,29,31,33 
Prolonged labour has been shown to be a risk factor for the development of an SSI. The 
longer the labour, the more likely the patient is to have multiple vaginal examinations, 
increased time during which infection can occur, and the greater likelihood of having an 
emergency CS.33  
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The patient’s endogenous skin flora are often found to be the causative organisms in SSIs, 
and appropriate cleaning of skin is aimed at reducing this risk.37 Iodine based preparations 
have been found to be superior in their effectiveness against gram positive and negative 
organisms in preoperative skin antisepsis.24,40 Hair clipping is more effective and safer as a 
pre-operative hair removal method, and results in lower incidence SSIs when compared to 
shaving.16,38  
Hypothermia during surgery causes vasoconstriction and therefore reduces tissue 
oxygenation, as well as decreases production of leucocyte superoxide. Transfusion 
requirements are also increased with hypothermia and bleeding is increased. For this reason, 
perioperative normothermia is advocated.48,49  
 
2.14 Best Care Always Initiative 
Best Care Always (BCA) is an initiative campaign that supports healthcare organisations in 
the implementation of interventions that are internationally evidence based to improve patient 
safety and institute the best current practice in hospital care. They have numerous 
interventions, and their recommendations in reducing and preventing SSIs are described 
below.7 The BCA principles were launched in the Western Cape in 2011, and subsequently 
introduced at MMH. 
2.14.1 Antimicrobial coverage 
This bundle advocates for the timely administration of the correct dose of prophylactic 
antibiotics pre-caesarean section. It also advises that a further prophylactic dose is given if 
the surgery extends beyond 4 hours.  
2.14.2 Appropriate hair removal 
A hibiscrub bath or shower should be performed prior to hair removal. It is advised that hair 
be removed using clipping or that it not be removed at all, and shaving is not recommended. 
Clipping should occur 2 hours or more prior to the time of surgery, followed by a pre-
operative hibiscrub bath or shower. Hair should not be removed in the operating theatre. 
Chlorhexidine 0.05% in 70% alcohol preparation should be used to clean the skin inside the 
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operating theatre, and given 3 minutes to dry prior to the skin incision being made. Washing 
of the abdomen is not advised for 6 hours post-operatively. 
2.14.3 Postoperative glucose control 
Strict glucose control should be instituted for major cardiac surgery patients cared for in an 
ICU. 
2.14.4 Peri- and post-operative normothermia 
Operating theatres should be kept at a constant temperature of 19-21˚C. Patient’s should be 
dressed in a cap and booties, with use of a bair-hugger intra-operatively. Pooling of 
preparation cleaning fluid should be kept to a minimum and the use of warmed IV fluids is 
advised. If intra-abdominal lavage is performed, this should be done with warm lavage fluids. 
The temperature should be monitored in recovery, and the bairhugger used when necessary to 
maintain normothermia.  
 
2.15 Rationale For Study 
Surgical site sepsis is an important cause of maternal morbidity and mortality, and can be 
considered a key indicator of quality of care. Due to the perceived increase in SSI in 2011/ 
2012, it was important to investigate the extent and nature of SSI post-CS in our population, 
which is known with a high prevalence of HIV and cephalopelvic disproportion. 
By describing the patients with SSI post-CS, we can recognise possible aspects that may be 
linked to the development of infection. This will then assist with development of an 
appropriate prevention strategy, early detection and appropriate management plan, which can 
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3. Aim and Objectives 
 
3.1 Aim  
The aim of this study was to review deep incisional and organ/space SSI following CS at 
MMH from December 2011 to December 2014. 
 
3.2 Specific Objectives 
 
1. To measure the incidence of SSI at MMH between December 2011 and December 2014. 
2. To describe the obstetric, medical and surgical factors associated with deep incisional 

















4.1 Study Design 
This was a retrospective observational case series. 
 
4.2 Study Setting  
The obstetric services within the Metro-West consist of Midwife Obstetric Units (MOUs), 
secondary level hospitals and a tertiary level teaching hospital. The MOUs are primary health 
care units and pregnant patients regarded as low risk, are referred to this service. In addition, 
patients requiring hospital delivery may attend here until 36-weeks gestational age. MMH is a 
secondary level hospital and patients who have complications in pregnancy are referred here. 
Indications for referral include, amongst others, twin pregnancies, previous stillbirth, 
antepartum haemorrhage and mild hypertension. The tertiary referral unit for our service is 
the Maternity Centre at GSH. Women who require inter-disciplinary care, have medical 
conditions or major obstetric complications are referred here. The Gynaecology Unit at GSH 
also looks after patients who have postpartum complications, such as severe SSI.  
Our study setting included both MMH and GSH, as patients with SSI were admitted to both 
hospitals. MMH, as a secondary level obstetric and neonatal hospital, does not have the 
capacity to treat cases of non-responsive SSIs and therefore these cases are referred to GSH, 
where they receive further treatment and management in the gynaecology wards. In addition, 
patients that were previously discharged postpartum from MMH, but present at a later stage 
with signs and symptoms of SSI, are referred and admitted directly to GSH gynaecology. 
 
4.3 Study Population 
The study population consisted of all patients who had a CS performed at MMH between 
December 2011 and December 2014. 
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At the commencement of the study in 2011, the patient population of Mowbray comprised of 
patients that lived in the local drainage area, as well as those transferred from the referring 
MOUs – namely Mitchell’s Plain MOU, Guguletu MOU, and Khayelitsha Site B MOU. Mid 
2012, the Khayelitsha District Hospital opened, and resulted in a shift in the referral platform. 
Khayelitsha Site B MOU now referred to either the District Hospital or Tygerberg Hospital, 
and MMH became the referral site for Retreat MOU and False Bay Hospital. 
 
4.4 Study Subjects 
The subjects for the current study were women who had a CS performed at MMH, who 
subsequently developed deep wound sepsis and/or uterine sepsis, as defined by the CDC 
(Appendix A). The subjects included those observed to develop severe SSI at MMH in the 
postoperative period, or identified after readmission from home with severe SSI.  
 
4.5 Inclusion Criteria 
- Patients with deep incisional SSI or organ/space SSI (as defined by the CDC), following 
CS at MMH between December 2011 - December 2014 
- Any patient that was readmitted or transferred to GSH (Gynaecology ward or Maternity 
Centre) for SSI, following a CS at MMH 
 
Exclusion Criteria 
-     Normal Vertex Deliveries 
-     Superficial SSI 
-     Sepsis from another source e.g. respiratory 
 
4.7 Definitions for Severe SSI Used to Identify Subjects 
For the purpose of this study, a deep incisional SSI consisted of a severe deep wound 
infection with an associated pyrexia of > 38⁰C, which required IV antibiotics, surgical 
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intervention in the form of wound debridement and drainage of any underlying collection. An 
organ/space SSI post-CS referred specifically to uterine sepsis, which required either IV 
antibiotics, uterine evacuation or hysterectomy. On examination, the uterus would be 
subinvoluted and tender. In addition, localised or generalised peritonitis may be elicited. 
Cases that did not respond to IV antibiotics required surgical intervention. This 
differentiation was made per a review of the literature that looked at diagnosis and 
management of SSI post-CS. 
 
4.8 Identification of Cases  
Postnatal wards at MMH are required to keep a book that records all septic cases. All patients 
that were transferred to GSH for wound sepsis and met the definition and criteria for either 
deep incisional SSI or organ/space SSI, as described in Appendix A, were recorded. Patients 
discharged from MMH, who presented with sepsis were readmitted to GSH Gynaecology 
wards, as logistically they were not able to be managed at MMH. GSH gynaecology wards 
kept a similar book to record all cases admitted from MMH. The relevant referral MOUs, 
namely Guguletu, Mitchells Plain, Khayelitsha and Retreat MOU, as well as False Bay 
Hospital, also kept a register of postnatal sepsis of patients who had undergone surgery at 
MMH. If surgical procedures were performed or any organism cultured from the wound, 
these were recorded as well. These statistics were collected on a weekly basis. 
 
4.9 Data Collection  
The relevant case folders were sourced from the Records Departments at both MMH and 
GSH, and analysed by myself as the principal investigator. The Maternity Case Record 
(MCR) is a booklet used nationally in South Africa, which is used throughout the antenatal as 
well as postpartum period. Included in the MCR are all the booking investigations, 
examination findings, antenatal symphyseal-fundal growth charts and space to record 
pertinent information. There is an intrapartum Philpot chart as well as a CS component. The 
neonatal APGAR (Appearance, Pulse, Grimace, Activity, Respiration) scores and 
examination findings can also be recorded. Data collected from individual patient folders was 
coded and then recorded on the Data Collection Sheet (Appendix B). The variables used in 
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the data collection sheet (DCS) were developed using the information gained from an 
extensive review of the lietrature on relevant risk factors, as well as basic patient 
demographics. Each case was given a consecutive individual study number and the data 
transferred from the DCS to an Excel spreadsheet using the study number as the only 
identifying factor. The study number and patient details were recorded separately and kept in 
a secure location, only accessible to the principal investigator, to ensure patient 
confidentiality. The Excel spreadsheet was kept on a password protected computer, again, to 
ensure confidentiality.  
 
4.10 Sample Size 
From clinical observations of approximately 2 - 3 women with post-CS SSI per month 
delivered at MMH, it was estimated that from 2011 to 2014 there would be at least 100 
subjects. This was thought to be a sufficient number from which to draw some conclusions 
for the study objectives. 
By using the incidence of SSI from 3 different studies and the monthly estimated delivery 
rate, an expected number of cases can be calculated. MMH has an average of 1000 deliveries 
per month, with roughly a 40% CS rate during the study time period. The incidence quoted in 
3 of the studies that used a similar SSI definition was 3.7% (Israel),6 0.7% (China)11 and 
1.5% (Johannesburg, South Africa).23  
 
Monthly deliveries at MMH:                              1000 deliveries 
CS rate:                                                                40% 
Monthly CS cases at MMH:                                400 
Literature incidence range of SSI:                       0.7 - 3.7% 
Estimated incidence of SSI cases per month:       2.8 - 14.8 
Estimated incidence of SSI cases over 3 years:    100.8 - 532.8 
 
The estimated number of cases of post-CS SSI is between 100 and 532 according to our 
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4.11 Data Analysis 
The incidence of SSI, defined as deep incisional SSI and/or organ/space SSI, following CS at 
MMH, was the primary measurement. These cases were named the numerator and all CS 
done at MMH during the given time period, the denominator. Data was analysed by myself 
and a statistician using statistical programmes, Statistica and Stata.  
Continuous variables were analysed and measured for central tendency (mean) and measures 
of dispersion (minimum, maximum and standard deviation). Categorical variables were 
placed into frequency tables. 
 
4.12 Ethics 
The study number and patient details were recorded separately and kept in a secure location, 
only accessible to the principal investigator, to ensure patient confidentiality. The Excel 
spreadsheet was kept on a password protected computer, again to ensure confidentiality.  
The research was conducted in line with the principles of the Helsinki Declaration.50 
Permission to conduct the study was obtained from the Department of Obstetrics and 


















Between December 2011 and December 2014, 98 patients were identified with deep and/or 
organ/space SSI following CS performed at MMH. Of the 98 cases, 96 patient folders were 
retrieved from the Records Department. The patient folders consist of the MCR, nursing 
notes, prescription charts, surgical notes and laboratory results.  
 
In the case of 29 patients, the MCR was not available, which has most the needed 
information. Of these 29 patients, 27 were MMH folders and 2 were GSH folders. The 
missing MCR could be due to the MCR remaining in the MMH folder on discharge and the 
patient representing to GSH, being misplaced at either MMH or GSH, or being an unbooked 
patient who never given a MCR. In cases where the MCR was not available, theatre and 
delivery registers were used to complete some of the missing variables, as well as laboratory 
reports. 
Patients with SSI were either transferred from MMH or discharged and then readmitted to 
GSH at a later stage. Transfers occurred in 35 patients (35.7%), readmission in 58 (59.2%) 
and 5 patients (5.1%) had this data missing. The mean hospital admission ranged from 2 to 36 
days, with a mean stay of 12.3 days (SD ±6.4 days). 
 
5.1 Incidence of post CS SSI 
During the outlined time period (December 2011 – December 2014), 14982 CS were 
performed. Of the 14982 caesarean sections, 98 were subsequently identified with deep 
incisional and/or organ/space SSI, according to the CDC definition, which results in an 
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Table 1 shows the incidence of severe SSI in a month by month breakdown over the 3-year 
study period, reflected as a percentage. The annual rate was calculated to be 0.88% for Year 
1, 0.90% for Year 2 and 0.70% for Year 3. This is represented graphically in Figure 2. 
 
 
Table 1:  Incidence of post CS SSI at MMH within study period  
Month 
Dec 2011 - Nov 2012 
SSI % Year 1  
Dec 2012 - Nov 2013 
SSI % Year 2 
Dec 2013 - Nov 2014 
SSI % Year 3 
December 2.23 0.48 0.48 
January 1.69 1.23 0.23 
February 0.51 1.72 1.72 
March 1.06 0.71 0.48 
April 0.6 1.28 0.85 
May 0.52 1.41 1.04 
June 0.95 1.67 1.24 
July 0.53 0.65 0 
August 0.75 0.41 0.26 
September 1.45 0.21 0.79 
October 0 0.84 1.01 
November 0.25 0.24 0.28 
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Figure 2 depicts the month to month incidence of SSI, expressed as a percentage. The months 
with an incidence above 1.5% included December 2011, January 2012, February and June 
2013 and February 2014. 
 
 





5.2 Patient Demographics 
Table 2 shows the descriptive data of the included patient demographics. The patient’s ages 
ranged from 16 to 43 years of age with a mean age of 25.6 (SD ±6.06). Of the 98 patients, 97 
patients had information regarding the number of previous CS, with a median of 0 (range 0-2, 
SD ±0.4). BMI was calculated using height and weight. The mean BMI of 59 patients was 
31.2, with a range from 17.98 – 56.03kg/m2 (SD ±6.95). In the remaining 39 patients, the 
height and/or weight had not been documented, or the MCR was missing, therefore the BMI 
could not be calculated. Of the 59 patients, 14 were overweight (BMI 25 – 29.9kg/m2), 27 
were obese (BMI 30.0 – 39.9kg/m2) and 7 were morbidly obese (BMI ≥40.0kg.m2).The mean 
weight of 67 patients was 78.15kg, with a range of 41.0 – 126.6kg (SD ±18.09). Again the 
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Minimum Maximum Mean/Median Std. Dev. 
Age 98 16 43 25,602 6,064 
Gravidity 97 1 6 1 1,196 
Parity 97 1 6 1 1,016 
Previous number of CS 97 0 2 0,155 0,441 
Previous number of 
laparotomies 
89 0 1 0,045 0,208 
Booking Haemoglobin 
(g/dL) 
71 7,5 15,3 11,375 1,722 
Height (in m) 59 1,45 1,73 1,575 0,063 
Weight (in kg) 67 41 126,5 78,157 18,086 
BMI (kg/m2) 59 17,982 56,304 31,241 6,948 
 
 
Table 3: Antenatal Data 
Column1 n % 
Booking 
  Booked 79 80.6 
Unbooked 2 2.0 





Negative 74 75.5 
Positive 24 24.5 





No 69 70.4 
Yes 11 11.2 
Unknown 18 18.4 
   Multiple pregnancy 
  Singleton 96 98.0 
Multiple pregnancy 2 2.0 
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Table 3 depicts antenatal data that was coded, as a frequency table. Of the 98 identified 
patients, 74 (75.5%) were HIV negative and 24 (24.5%) were HIV positive. When reviewing 
the treatment of the 24 HIV positive patients, 1 patient (4.2%) was not on antiretroviral 
treatment, 10 (41.7%) were receiving Prevention of Mother To Child Transmission (PMTCT) 
treatment, 11 (45.8%) patients were on lifelong Highly Active Anti-Retroviral Therapy 
(HAART), and 2 (8.3%) patients had missing data for the variable. Investigation into the 
smoking habits of the cases revealed that 11 (11.2%) patients did smoke cigarettes, 69 
(70.4%) patients did not smoke, and in 18 (18.4%) cases this information was unknown. With 
regards to the unknown data, this was either due to the information not having been recorded, 
or that the MCR could not be retrieved. 
 
5.3 Intrapartum Data 
Intrapartum characteristics are represented in Table 4. Of the 98 patients, 79 patients (80.6%) 
were in labour prior to CS, 10 patients (10.2%) were not in labour and 9 (9.2%) had this 
variable missing. PROM was defined as rupture of membranes for more than 24 hours. 
PROM was present in 16 patients (16.3%), 63 (64.3%) did not have PROM and 19 (19.4%) 
patients in which this information was not known. Prolonged labour was defined as the active 
phase of labour lasting > 10 hours and/or total labour lasting > 18 hours. Of the 98 patients, 
32 (32.7%) had a prolonged labour, 41 (41.8%) did not, and 25 (25.5%) had this variable 
missing. As stated before, the MCR was missing in 29 cases, but data regarding prolonged 
labour was extrapolated from other clinical notes in 4 cases, leaving 25 cases with this data 
labelled as unknown. 
 With regards to vaginal examinations prior to CS, 74 patients had data regarding this 
variable, with a range of between 0 and 11 vaginal examinations, and a median of 5 (SD 
±2.8). Intrapartum temperature is not presented in Table 4, however, information for this 
parameter was found for 64 of the 98 cases. In these cases, the mean temperature in labour 
was calculated to be 36.4˚C (35.0-38.5, SD ±0.7). In the remaining 34 cases, the temperature 
was not recorded in 5 cases and in 29 cases the MCR was missing. A temperature of ≥ 38.0˚C 
was found in 2 patients, which equates to 3.1% of all cases that had a raised temperature 
recorded. 
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Table 4:  Intrapartum Data 
 
n % (n=98) 
Labour 
  No 10 10.2 
Yes 79 80.6 
Unknown 9 9.2 
   Induction of labour 
  No 62 63.3 
Yes 20 20.4 
Unknown 16 16.3 
   Prolonged labour  
  No 41 56.2 
Yes 32 43.8 
Unknown 25 25.5 
   Failed instrument 
  No 91 92.9 
Yes 3 3.0 
Unknown 4 4.1 
 
5.4 Operative Data 
An emergency CS was performed in 90 patients (91.8%), 7 (7.2%) had an elective CS and 1 
patient (1.0%) had this variable missing (Table 5). The primary surgeon was a registrar in 37 
cases (37.8%), a senior medical officer (MO) in 39 (39.8%), a junior MO in 18 (18.3%) and 4 
(4.1%) had this data missing. The mean pre-operative haemoglobin was found to be 11.8g/dL 
with a SD of ± 1.7g/dL. Antibiotics at time of CS were received in 62 patients (63.3%), not 
received in 1 (1%) and unknown in 35 (35.7%). This high number of unknown data is due to 
the fact that in 29 cases, the MCR was missing, and the anaesthetic chart on which the 
preoperative antibiotics are prescribed is contained within the MCR. In a few cases, the 
antibiotics were prescribed but not signed for. 
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Table 6 describes the operative data from the surgery of the cases that subsequently 
developed SSI. 
The skin incision made was a Pfannenstiel incision in 91 (92.9%) patients (Table 6), a 
midline incision in 4 (4.1%) and unknown in 3 (3.0%) patients. The uterine incision made 
was a lower segment uterine incision (LSUI) in 87 (88.8%) cases, a classical incision in 5 
Column1 n % (n=98) 
Caesarean section 
  Emergency 90 91.8 
Elective 7 7.2 
Unknown 1 1.0 
   Surgeon 
  Registrar 37 37.8 
Senior MO 39 39.8 
Junior MO 18 18.3 
Unknown 4 4.1 
   Anaesthetic 
  Spinal 88 89.8 
General 4 4.1 
Combination 2 2.0 
Unknown 4 4.1 
   Preoperative 
prophylactic 
antibiotics 
  Received 62 63.3 
Not received 1 1.0 
Unknown 35 35.7 
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(5.1%), either a J-shaped incision or a combination of LSUI with a classical incision was 
made in 2 (2.0%) patients and unknown in 4 (4.0%).  
MSL was present in 22 patients (22.4%), was not found in 47 (48.0%) and unknown in 29 
cases (29.6%).  Chorioamnionitis was suspected by the presence of offensive liquor at time of 
CS in 16 cases (16.6%), not suspected in 59 cases (60.2%) and unknown in 23 cases (23.5%). 
Skin closure was achieved with interrupted sutures in 90 patients (91.8%), continuous sutures 
in 4 (4.1%) and unknown in 4 cases (4.0%). The mean estimated blood loss was 565 
millilitres with a SD of ± 368 millilitres.  The operating time for 93 patients was between 10 
and 167 minutes, with a mean of 33.6 minutes (SD ±22.9). The remaining 5 cases did not 
have both the start and end time documented or the folder was missing. 
Table 7 depicts additional procedures during CS. An intrauterine contraceptive device 
(IUCD) was inserted in 3 (3.0%) patients, not inserted in 91 (92.9%) and unknown in 4 cases 
(4.0%). Of the 93 cases where documentation could be found, no surgical drains were 
inserted. A B-lynch compression suture was inserted in 5 patients (5.1%), 1 patient (1.0%) 
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Table 6:  Operative Data 
Column1 n % (n=98) 
Skin incision 
  Pfannenstiel 91 92.9 
Midline 4 4.1 
Unknown 3 3.0 
   Uterine incision 
  LSUI 87 88.8 
Classical 5 5.1 
Other 2 2.0 
Unknown 4 4.1 
   Chorioamnionitis 
  Yes 16 16.3 
No 59 60.2 
MSL 
  Yes 22 22.4 
No 47 48.0 
Unknown 29 29.6 
   
Skin sutures 
  Interrupted 90 91.8 
Continuous 4 4.1 
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Table 7: Additional Operative Procedures 
 n % (n=98) 
IUCD 
  Inserted 3 3.0 
Not inserted 91 92.9 
Unknown 4 4.1 
   B-lynch suture 
  Inserted 5 5.1 
Not inserted 89 90.8 
Unknown 4 4.1 
   
Drain 
  Inserted 0 0.0 
Not inserted 93 94.9 
Unknown 5 5.1 
   Artery ligation 
  Yes 1 1.0 
No 93 94.9 
Unknown 4 4.1 
   Balloon 
tamponade 
  Yes 2 2.0 
No 92 93.9 




The post-operative diagnosis of SSI was divided into either deep incisional SSI or 
organ/space SSI, as per the CDC definitions used throughout the study.  Deep incisional 
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sepsis was deep infection of the wound, whilst organ/space SSI constituted uterine sepsis. 
The categories were also not mutually exclusive (Table 8).  
 
Table 8: Type of SSI 
 
N % (n=98) 
DEEP INCISIONAL SSI 
Wound sepsis 74 75.5 
   ORGAN/SPACE SSI 
Uterine sepsis 24 24.5 
 
Wound sepsis was diagnosed in 74 patients (75.4%), with 22 patients (22.5%) that were not 
eligible for our study as they had superficial SSI. Of the 98 patients, 24 (24.5%) were 
diagnosed with uterine sepsis, which was diagnosed by uterine tenderness and subinvolution, 
which may have included localised or generalised peritonitis. This variable was missing in 2 
patients (2.0 - 2.1%). RPOC was confirmed in 6 (6.0%) cases. 
 
5.6 Management 
Management was divided into: wound debridement, uterine evacuation, laparotomy, and 
hysterectomy. In 2 patients (2.0-2.1%) this information was missing (Table 9). All patients 
received IV antibiotics, with 34 patients (34.7%) requiring additional surgical procedures. Of 
the 74 patients diagnosed with wound sepsis, 23 had a debridement (31.1%). All patients 
diagnosed with RPOC had a uterine evacuation (6 of 6, 100%) and laparotomy was 





P a g e  | 45 
 
Table 9:  Management 
 
N % (n=98) 
   Debridement 
  Yes 23 23.5 
   Uterine evacuation 
  Yes 6 6.1 
   Hysterectomy
  Yes 12 12.3 
No 84 85.7 
Unknown 2 2.0 
   Laparotomy  
  Yes 17 17.2 
No 81 82.6 




Organisms were cultured either from a wound pus swab, retained products, wipes from the 
uterus, or uterine tissue. It was found that in 43 patients (43.9%), no organism was cultured, 
Methicillin-Resistant Staphylococcus Aureus was cultured in 12 (12.2%) cases, and 
Klebsiella pneumoniae in 18 (18.4%) cases. Multiple organisms were cultured in 16 (16.3%) 
patients. 
 
5.8 Morbidity Assessment  
Of the 98 patients identified with either deep incisional or organ/space SSI, none required 
intensive care unit (ICU) admission or ventilation. There were no maternal deaths. 





In total, 14982 caesarean sections were performed at MMH between December 2011 and 
December 2014. Of these, 98 were subsequently diagnosed with either deep incisional SSI or 
organ/space SSI, resulting in an incidence of 0,65%. This is a substantially lower figure than 
that reported in an Israelian study done over a 14-year time period, which found the incidence 
to be 3.7%.6 This study, however, included cases of both superficial and deep wound sepsis, 
whereas the cases identified in our study were only that of severe SSI, and therefore did not 
include cases of superficial SSI. 
Gong et al (2012) performed a study from 2005 – 2009 in 8 Chinese centres and had an 
incidence of SSI in 0.7%, calculated from 96 cases out of 13798 CS performed. These are 
very similar figures to this study and used the same inclusion criteria.11 In a South African 
study conducted at Chris Hani Baragwanath Academic Hospital over a 3-month period, the 
incidence of SSI was found to be 12.5% with mild SSI making up 11.0% and severe SSI only 
comprising of 1.5%.23 
The results from our study are in keeping with incidences found elsewhere. 
The incidence of SSI at MMH from December 2011 to December 2014, is represented in 
Figure 2. The lowest incidence was seen in year 3, December 2013 – November 2014. The 
introduction of BCA was first made in August 2011 in a step wise fashion. The introduction 
of the bundles was erratic due to a time delay in sourcing hair clippers, which took 18 
months. The operating theatres were also renovated during the study period which included 
removal of all wooden fixtures, installation of stainless steel splashboards behind the scrub 
basins and the replacement of all the air-conditioning filters. All of the BCA bundles had 
therefore been introduced by year 3. Another contributing factor may be the change in 
drainage area over the study period. Khayelitsha, which initially referred to MMH, was 
diverted to another drainage area, and as this community has one of the highest HIV 
incidences in Cape Town, this may have had an impact on the decrease in incidence of SSI. 
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6.2 Patient Demographics 
The mean age of the patients included in this study was 25.6 years (16-43). This is in keeping 
with other study populations.6,11 The median number of previous CS was 0 (0-2), which is 
similar to Wloch et al (2012), who had 63.1% of the cases having had no previous CS.27 This 
goes against the school of thought that previous CS may predispose a patient to SSI, due to 
lengthy or more difficult surgery.11,22 Scheid-Kofman et al (2005) found that there was no 
increase in SSI in patients with a previous CS and attributed this to possible early 
mobilisation in the more experienced patient who had undergone previous surgery.6 This 
could also be explained by the fact that most primigravid patients tend to be in labour and 
then require an emergency CS, whereas more patients with a previous CS would have 
elective surgery. The higher SSI rate could therefore be attributed to intrapartum risk factors. 
The mean BMI was found to be 31.2kg/ m2 and the mean weight was 78kg. Of the 59 patients 
where a BMI could be calculated, 27 (45.8%) were obese and 7 (11.9%) were morbidly 
obese, which is an extremely large percentage of the patients. Ghuman et al (2011) had a 
mean BMI of 34.7kg/ m2 in the case group and 28.0m2/kg in the control group.33 Obesity is a 
proven risk factor for the development of post CS SSI and there is an increased likelihood of 
developing SSI with each increasing BMI category.6,27,30  
Of the cases included in our study, 24.5% were HIV positive, which is higher than the HIV 
statistics for the Western Cape, which ranged between 18.3-18.5% in women aged 15 – 49.51 
Although our study was not powered to show any associations, the increased incidence of 
HIV in our study population may point towards HIV being a risk factor for developing SSI. 
Our study did not include CD4 counts or viral loads, which was a limitation of our study and 
may have helped to differentiate women who may have been at risk of developing SSI. In 
another South African study, 12 patients who were HIV positive had puerperal infection 
(35%), and 67 HIV positive patients had no sign of puerperal infection (28%), although this 
was not shown to be statistically significant.23 This study also did not comment on CD4 
counts or viral loads. 
 
6.3 CDC Definition 
The CDC definition of SSI (Appendix A), which was used throughout this study, was 
difficult to apply in the case of post-CS SSI. The category of deep SSI was divided into 
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incisional and organ/space SSI. Deep incisional SSI is straightforward, but in the case of 
organ/space SSI, in this instance uterine sepsis, there are different possible interpretations. 
For instance, we decided to include endometritis together with uterine sepsis in the organ SSI 
group. One could counter argue that endometritis, although in the organ itself is superficial 
and is often managed with IV antibiotics alone, whereas a septic uterus, or endomyometritis, 
will require hysterectomy. Since there is no alternative definition for SSI, we used the broad 
CDC definition, which is applied throughout the surgical disciplines. 
 
6.4 Obstetric Risk Factors 
Obstetric risk factors that increase the incidence of post CS SSI are generally intrapartum risk 
factors, which makes SSI post-CS unique when compared to elective surgery and it is often 
impossible to differentiate between infection that was introduced during labour or at the time 
of surgery.  
This study found that 80.6% of the patients had been in labour, and 32.7% had prolonged 
labour. The median number of vaginal examinations was 5 and 32.7% of patients had PROM. 
Increased number of vaginal examinations in labour and PROM were shown to significantly 
increase the risk of SSI.11 Schneid-Kofman et al (2005) observed that patients with PROM 
had an increased risk of developing a SSI, then patients without PROM and Ghuman et al 
(2011) discovered than their case group had a longer length of labour than the control 
group.6,33  
Majority of the patients were in labour (80.6%) and almost a third (32.7%) had PROM. 
Sterile vaginal examinations are imperative, specifically in the case of ruptured membranes. 
The aseptic technique limits the amount of vaginal flora that is introduced during the VE.52 
The 2015 South African Guidelines for Maternity Care advise VE every 2 hours in the active 
phase of labour, therefore making sterile VE essential.53 Even though IOL was not found to 
be associated with SSI, at MMH the practice of AROM and oxytocin infusion is used. 
 
6.5 Operative risk factors 
An emergency CS was performed in 91.8% of the cases. There is a multitude of evidence that 
suggests that one of the most significant risk factors for developing post CS SSI, is an 
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emergency CS in labour.5,6,10,33 This can be attributed to risk factors that are not associated 
with an elective CS; prolonged labour, multiple VE, PROM, disimpaction of fetal head, 
suboptimal skin preparation, and incorrect timing of prophylactic antibiotics in an 
emergency. It is therefore unsurprising that the vast majority of the patients with severe SSI 
had an emergency procedure. 
The grade of surgeon was equally divided between a registrar and senior medical officer. 
Very few CS were performed by junior staff, which may be due to the fact that these CS were 
more technically difficult or merely coincidental. Wloch et al (2012) discovered that a CS 
performed by a more junior surgeon had an increased odds ratio of 1.6 for developing SSI.27  
Prophylactic antibiotics were given timeously in 63.3% and not recorded in 35.7%. This 
emphasises the importance of proper record keeping as one cannot assume that antibiotics 
were administered in these cases, although the most likely case is that they were. The 
protocol prescribes that antibiotics are administered prior to the patient being taken into the 
operating theatre to therefore allow adequate time before the skin incision is made. 
  
6.6 Diagnosis and Management 
Most the patients that had wound sepsis (75.5%) required IV antibiotics and/or debridement. 
Wound sepsis was diagnosed in 74 patients and a debridement was performed in 23 patients 
(31%), with IV antibiotics being the mainstay of treatment. A small percentage had retained 
products of conception and 100% of patients diagnosed with RPOC had a uterine evacuation 
performed. 
Uterine sepsis was found in 13.3% of cases, and this is regarded as the most severe form of 
SSI.  It can be seen as a near miss occurrence, as uterine sepsis can lead to maternal 
mortality. Of the 13 cases of uterine sepsis, 12 had a hysterectomy performed (92%). This 
indicates that the correct diagnosis was made with appropriate treatment. There were also no 
ICU admissions and no deaths, which also is an indicator of good clinical care. In South 
Africa, Essential Steps in Management of Obstetric Emergencies (ESMOE) training is being 
carried out in most centres. The aim is to equip junior medical and nursing staff with the 
skills needed to manage emergencies such as postpartum sepsis. The teaching in these 
manuals is that if the patient is in septic shock and does not responding  to treatment and/ or 
has unresolving uterine sepsis with failure of one or more organs, then one must proceed to 
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laparotomy and probably a hysterectomy.54 By following the strategy described, a timeous 
hysterectomy will be performed, which may reduce maternal mortality. 
 
6.7 Microbiology 
The NNIS has identified pathogens that have been isolated from SSI. These include, but are 
not limited to: Staphylococcus aureus, coagulase-negative staphylococcus, Enterococcus, 
Escherichia coli, Pseudomonas aeruginosa, Enterobacter, Proteus mirabilis, Klebsiella 
pneumoniae, other Streptococcus, Candida albicans and Bacteroides fragilis. A growing 
number of SSIs are caused by antimicrobial-resistant organisms, such as MRSA. MRSA is a 
bacteria that causes infections which do not respond to standard broad spectrum antibiotics.  
It is significant in that it is a hospital acquired infection, and as it is a resistant organism, 
requires isolation and barrier nursing to prevent it’s transfer to other patients. In most cases, it 
is sensitive to Vancomycin.16  
In our study, an organism was cultured in 56.1%, with MRSA cultured in 12.1%, Klebsiella 
pneumoniae in 18.4%, polymicrobial in 16.3% and “other” organisms in 28.6%. Wloch et al 
(2012) identified a causative organism in 39.8% of SSIs, which were polymicrobial in 24%. 
Staphylococcus aureus was the most common organism (40%), with 17% being MRSA.27The 
National Health Laboratory Service’s Annual Surveillance Report of 2012 at GSH stated that 




At MMH, the recommendations at the time of the study were that all patients receive 
prophylactic pre-operative antibiotics and that in selected cases an extended course of 
antibiotics was prescribed (Appendix D).  
 Although there is no evidence in the literature that an extended course of prophylactic 
antibiotics has any clinical benefit, due to the intrapartum and operative risk factors, the 
MMH and Western Cape protocols recommend the extended course in specific situations, as 
is recommended in a 2014 Cochrane review.5,43,44,45 
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6.9 General Infection and Prevention Control 
General infection prevention and control (IPC) includes pre-operative showering/ bath, pre-
operative hair removal, patient skin preparation in theatre, pre-operative hand/forearm 
antisepsis by surgical staff, sterile instruments and antibiotic prophylaxis.16 IPC was not 
evaluated in our study although it is known to be a very important routine intervention in the 
prevention of hospital acquired infections, notably MRSA. 
 
6.10 Morbidity Assessment 
There were no maternal deaths or ICU admissions for the indication of SSI in our study 
population. Whilst this indicates prompt and quality care, we cannot be sure that patients did 
not present to another hospital or province, or that any patients could have demised at home 
before having opportunity to present to health care services. In reviewing the Metro West 
maternal mortality reports 2012 - 2014, there were no maternal deaths from sepsis related to 
CS in the Metro West. Therefore, our study group did not miss any deaths within our 
facilities from CS sepsis. 
Of note, 12 of the cases required hysterectomy thus fulfilling the criteria for 'near miss' or 
'acute severe maternal morbidity'. There is no reason why files of ICU admissions would 
have been more difficult to locate. In the Metro West there is an aggressive approach to 
performing hysterectomy with uterine sepsis, and that they are performed before the 
patients go into septic shock and therefore did not require ICU. GSH ICU has very strict 
criteria for admission. 
The second limitation is that our SSI rate is likely to be an underestimate due to the 
possibility of women with severe SSI presenting at other institutions in the 6-week post- 
partum period. Patients may have presented to other hospitals in the Western Cape or even 
travelled to other provinces. 
Readmission occurred in 59.2% of cases, which either indicates that the patient was well and 
developed a SSI later or that they were discharged with signs of infection which were 
possibly missed at time of discharge. The Saving Mothers Report advises that facilities are 
accessible for outpatient postnatal care for 6 days post-delivery and that on discharge women 
must be advised on the signs of infection and what to do in this instance.1 




The most important limitation in this study was that of missing folders, which resulted in the 
data set not being complete. Folders were retrieved from both MMH and GSH and in the case 
of the missing folders, these were not in the records department and were not able to be 
located either. In some instances, this information could be gathered from other sources, such 
as theatre or delivery registers. During the data collection period, it was noted that clinical 
notes were occasionally incomplete, or important information not recorded. Correct filing of 
folders and proper note-keeping is vital, not only for audit purposes, but for also for patient 
care and medicolegal purposes. Missing data made analysis of all 98 cases incomplete. 
Cases identified with SSI were not matched with controls, which would have made it possible 
to make associations for various risk factors, which would give the clinician more 
information regarding potential risk factors for post CS SSI in our population. 
As this was a retrospective review of cases, further information that was not in the clinical 
notes could not be obtained, for example specifics regarding pre-operative skin preparation. 
In a prospective study, one would be able to focus on the perceived associations involved 
with SSI. MMH has subsequently instituted a BCA ticksheet, which is completed for every 
patient undergoing a CS, and subsequently audited to assess the level of compliance with the 
BCA bundles of care.  
During this study, it was difficult to interpret possible trends with regards to SSI post-CS as 
there were so many changes throughout the study period; change in drainage area, 
unsynchronised introduction of BCA bundles and theatre refurbishments, amongst other 
factors, which make conclusions difficult. 
Specific associations could unfortunately not be made in this study as it was not designed or 
powered to do this. This could potentially be useful information that could result in 
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6.12 Recommendations 
As most of the cases of SSI were in labour, one can deduce that some of the risk factors may 
occur during the intrapartum period. Training sessions and posters in the labour ward can be 
instituted to teach and remind doctors and nursing staff to limit the number of VEs, strict 
adherence to aseptic techniques for VE and to follow antibiotic protocols. The BCA tick 
sheet that has since been instituted is a good example of a reminder to complete each step in 
order to facilitate the best prevention of SSI.  
Infection control in the labour ward and operating theatres also needs to be monitored to 
identify lapses and correct IPC techniques reinforced. 
Collection of data pertaining to CD4 counts and viral loads would be a recommendation for 
future studies and might aid in identifying patients at risk of SSI. 
To establish causative factors and make astute recommendations, there would need to be a 
prospective study with matched controls, which would also eliminate the difficulty in 

















During the study period 14982 CS were performed, with 98 being diagnosed with deep 
incisional or organ/space SSI. The overall incidence of severe SSI was calculated to 0.65%, 
which is in keeping with the incidence in other centres. The lowest incidence was found in 
year 3, which could be accounted for by the full implementation of the BCA bundles and 
change in drainage area. 
Of the 98 patients with severe SSI, 80.6% were in labour and 91.8% had an emergency CS 
performed. The majority of the patients diagnosed with SSI were in labour, which can be 
attributed to intrapartum risk factors increasing the likelihood for development of post-CS 
SSI.  
Uterine sepsis was diagnosed in 24.5% of patients and 12.3% required a hysterectomy. There 
were no maternal deaths or ICU admissions, which may indicate a good quality of care, but 
may also indicate that the missing folders may have included patients who were admitted or 
died elsewhere. 
A prospective study, powered to analyse specific associations between risk factors and the 
development of SSI post-CS is needed to fully evaluate and identify significant causes. This 
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9. Appendices 




Infection occurs within 30 days after the operation 
and 
infection involves only skin or subcutaneous tissue of the incision 
and at least one of the following: 
1. Purulent drainage, with or without laboratory confirmation, from the 
superficial incision. 
2. Organisms isolated from an aseptically obtained culture of fluid or 
tissue from the superficial incision. 
3. At least one of the following signs or symptoms of infection: pain or 
tenderness, localized swelling, redness, or heat and superficial 
incision 
is deliberately opened by surgeon, unless incision is culture-negative. 
4. Diagnosis of superficial incisional SSI by the surgeon or attending 
physician. 
 
Do not report the following conditions as SSI: 
1. Stitch abscess (minimal inflammation and discharge confined to the 
points of suture penetration). 
2. Infection of an episiotomy or newborn circumcision site. 
3. Infected burn wound. 
4. Incisional SSI that extends into the fascial and muscle layers (see 
deep incisional SSI). 
 
Note: Specific criteria are used for identifying infected episiotomy and 
circumcision sites and burn wounds. 
Deep Incisional 
SSI 
Infection occurs within 30 days after the operation if no implant† is left in 
place or within 1 year if implant is in place and the infection appears to 
be related to the operation 
and 
infection involves deep soft tissues (e.g., fascial and muscle layers) of the 
incision 
and at least one of the following: 
1. Purulent drainage from the deep incision but not from the 
organ/space component of the surgical site. 
2. A deep incision spontaneously dehisces or is deliberately opened by a 
surgeon when the patient has at least one of the following signs or 
symptoms: fever (>38°C), localized pain, or tenderness, unless site is 
culture-negative. 
3. An abscess or other evidence of infection involving the deep incision 
is found on direct examination, during reoperation, or by 
histopathologic or radiologic examination. 
4. Diagnosis of a deep incisional SSI by a surgeon or attending 





1. Report infection that involves both superficial and deep incision sites 
as deep incisional SSI. 




Infection occurs within 30 days after the operation if no implant† is left in 
place or within 1 year if implant is in place and the infection appears to 
be related to the operation 
and 
infection involves any part of the anatomy (e.g., organs or spaces), other 
than the incision, which was opened or manipulated during an operation 
and at least one of the following: 
1. Purulent drainage from a drain that is placed through a stab wound‡ 
into the organ/space. 
2. Organisms isolated from an aseptically obtained culture of fluid or 
tissue in the organ/space. 
3. An abscess or other evidence of infection involving the organ/space 
that is found on direct examination, during reoperation, or by 
histopathologic or radiologic examination. 
4. Diagnosis of an organ/space SSI by a surgeon or attending physician. 
 
* Horan TC et al11 
† National Nosocomial Infection Surveillance definition: a nonhuman-derived implantable foreign 
body (e.g., prosthetic heart valve, nonhuman vascular graft, mechanical heart, or hip prosthesis) 
that is permanently placed in a patient during surgery. 
‡ If the area around a stab wound becomes infected, it is not an SSI. It is considered a skin or soft 
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9.2 Appendix B: Data Collection Sheet 
 
Study number     
Age     
Gravidity     
Parity     
Previous Caesarean Sections (number)     
Previous Laparotomies (number)     
Booked 0=No 1=Yes     
Haemoglobin at booking (g/dl)     
HIV Positive 0=No 1=Yes     
HIV Treatment 0=No 1=Yes PMTCT 2=Yes 
HAART   
RPR Positive 0=No 1=Yes     
RPR Treated 0=No 1=Yes 2=Partially   
Number of Antenatal Visits     
Smoking 0=No 1=Yes     
Height (in meters)     
Weight (in kilograms)     
Body Mass Index     
Impaired Glucose Tolerance 0=No 1=Yes     
Multiple Pregnancy 0=No 1=Yes     
Temperature (in degrees Celsius) prior to 
delivery     
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Induction of Labour 0=No 1=Yes     
Prolonged Rupture of Membranes (>24hrs) 
0=No 1=Yes      
In Labour 0=No 1=Yes   
Prolonged Labour (active phase>10hrs, total 
labour >18hrs) 0=No 1=Yes      
Vaginal Examinations (number)     
Failed instrumental delivery 0=No 1=Yes      
Disimpaction of fetal head 0=No 1=Yes     
Antibiotics prior to caesarean section 0=No 
1=Yes      
Elective caesarean section 0=No 1=Yes      
Surgeon 0=Registrar 1= Senior Medical 
Officer 2=Junior Medical Officer 3=Intern 
4=Consultant     
Start time (00:00)     
End Time (00:00)     
Operation Time (00:00)     
Pfannenstiel incision 0=No 1=Yes      
Uterine incision 0=Lower uterine incision 
1=Classical 2=Other     
Haemoglobin at time of caesarean section 
(g/dl)     
Estimated Blood Loss (ml)     
Spinal anaesthesia 0=No 1=Yes 
2=spinal+GA     
Antibiotics before skin incision 0=No 1=Yes      
Suspected chorioamnionitis 0=No 1=Yes      
Meconium stained liquor 0=No 1=Yes     
Chromic used on uterus 0=No 1=Yes      
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IUCD inserted 0=No 1=Yes      
Interrupted skin sutures 0=No 1=Yes      
Drain inserted 0=No 1=Yes  
 
  
Additional procedures at CS: B lynch  0=No 
1=Yes 
  Additional procedure: Artery ligation 0=No 
1=Yes   
Additional procedure: Balloon tamponade 
0=No 1=Yes   
Antibiotics after caesarean section 0=No 
1=Yes     
Postop Pyrexia (>37.0⁰C for 4 or more days) 
0=No 1=Yes 
  
Readmission 0=No 1=Yes  
 
  
Final diagnosis: wound sepsis 0=No 1=Yes    
Final diagnosis: RPOC 0=No 1=Yes   
Final diagnosis: endometritis 0=No 1=Yes   
Final diagnosis: septic uterus 0=No 1=Yes   
Definitive mx IV abx 0=No 1=Yes  
 
  
Definitive mx wound debridement 0=No 
1=Yes   
Definitive mx EVAC 0=No 1=Yes   
Definitive mx hysterectomy 0=No 1=Yes   
Definitive mx laparotomy 0=No 1=Yes   
   MRSA cultured 0=No 1=Yes 
  
Klebsiella pneumoniae cultured 0=No 1=Yes   
Other organism cultured 0=No 1=Yes 
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9.3 Appendix C:  MMH BCA – SSI Checklist 
PERI-OP NORMOTHERMIA APPROPRIATE HAIR REMOVAL ANTIMICROBIAL COVERAGE 
ACTION RESULT 
 If done 
X     If not  
Or  N/A 
ACTION RESULT 
 If done 
X     If not  
Or  N/A  
ACTION RESULT 
 If done 
X     If not  
Or  N/A 
 Theatre temp between 19 & 
21 degrees  
 Patient dressed in a cap & 
booties  
 Bair Hugger used intra-
operatively 
 Minimal pooling of prep fluid 
 Warm IV fluids used  
 Warm lavage fluids used 
 Temp in recovery 









 No shaving done at home 
 No shaving in hospital 
 Clipping done pre-op 
 Clipping not done 
operating room 
 Clipping done < 2 hours 
pre-op 






 Antibiotic given within 60 min 
of incision 
 Correct dose given 
 Re-dosing done (if >than 4 
hrs) 
 Pre-op hibiscrub bath/shower  
 Hibiscrub bath /shower after 
hair removal 
 Chlorhexidine 0.05% in 70% 
alcohol prep  
 3 min given for skin drying 
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9.4 Appendix D: Antibiotic Protocol at MMH 
 
ANTIBIOTICS AT MMH 
 
 
The following guidelines apply to patients in whom the clinical situation requires antibiotics for 




A. Acute Pyelonephritis 
 
 Ceftriaxone 1g ivi stat, then 1g daily for 3 - 5 days, followed by oral Co-amoxiclav (if > 34      
 weeks gestation) or oral cefuroxime (< 34 weeks gestation) - depending on culture results.   
 Treatment should be for a duration of at least 10 days. 
 
B. Bacterial Pneumonia (community acquired) 
 
Ceftriaxone 1g ivi stat, then 1g daily for 3 - 5 days, followed by oral Co-amoxiclav or 
cefuroxime as above - depending on culture results. Treatment duration is based primarily 
on clinical response, but would usually be about 5-7 days. 
 
C.    Vaginal Discharge 
         
- Flagyl 400mg po 8hrly  
- Clotrimazole Vaginal Cream 
 
        Patients not responding to above therapy require a speculum examination, and the   
        addition of the following antibiotics:  
 
- Amoxil 500mg po 8hrly 
- Ceftriaxone 1g IM stat 
 
NB – Treatment of partners + condom use 
 
 
E.  PPROM 
 
All patients admitted with PPROM that have no evidence of Chorioamnionitis, should 
receive: 
- Azithromycin 500mg daily x 3/7s (to prevent chorioamnionitis) 
- Ampicillin 1g ivi 6hourly when in labour (Gp B Streptococcus prophylaxis) or 
- Clindamycin 600mg ivi 8hourly if allergic to penicillin 
 
 
Group B Streptococcus 
 
The following are risk factors for the development of early onset GBS disease in the 
neonate: 
 
- Previous baby affected by GBS 
- GBS bacteriuria detected during current pregnancy 
- Preterm labour 
- Prolonged rupture of membranes 
- Fever in labour 
 
Patients with any of these risk factors should receive prophylaxis during labour: 
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- Ampicillin 1g ivi 6 hourly or
- Clindamycin 600mg ivi 8 hourly if allergic to penicillin




- Cefazolin 1g ivi stat if < 80kg
- Cefazolin 2g ivi stat if > 80kg
HIV positive: 
Pre-op 
- Cefazolin 1g ivi stat if < 80kg
- Cefazolin 2g ivi stat if > 80kg,
Post-op 
- Ceftriaxone 1g ivi stat daily x 5/7
- Metronidazole 400mg po 8 hourly x 5/7
NB – Please document DATE and TIME of prescribing antibiotics! 
B. Emergency C/S
Pre-op
- Cefazolin 1g ivi stat if < 80kg
- Cefazolin 2g ivi stat if > 80kg
Post-op 
- Ceftriaxone 1g ivi stat daily x 5/7
- Metronidazole 400mg po 8 hourly x 5/7
Prophylaxis/ Therapeutic Antibiotics 
The following are risk factors for the development of maternal sepsis: 
- Prolonged labour (active phase of more than 12 hours)
- > 5 vaginal examinations since the onset of labour
- PROM (> 24 hours)
- Disimpaction of fetal head during caesarean section
- Cord prolapse
- Chorioamnionitis
- Offensive liquor at C/Section
 Treat with Ceftriaxone ivi 1g daily + Metronidazole 400mg 8 hourly for 24 hours or for duration of
labour.
 Discharge from hospital on a 5 day course of oral antibiotics –
Amoxil 500mg 8hrly + Metronidazole 400mg 8hrly
PLEASE NOTE 
Any patient that is still pyrexial on Day 3 post delivery requires a septic workup. 
All of these patients should be discussed with the Obstetric Consultant. 
